Correlation Between Israel China and Homebiogas

Can any of the company-specific risk be diversified away by investing in both Israel China and Homebiogas at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Israel China and Homebiogas into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Israel China Biotechnology and Homebiogas, you can compare the effects of market volatilities on Israel China and Homebiogas and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Israel China with a short position of Homebiogas. Check out your portfolio center. Please also check ongoing floating volatility patterns of Israel China and Homebiogas.

Diversification Opportunities for Israel China and Homebiogas

-0.7

Correlation Coefficient

Israel China  Homebiogas

Excellent diversification

The 3 months correlation between Israel and Homebiogas is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Israel China Biotechnology and Homebiogas in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Homebiogas and Israel China is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Israel China Biotechnology are associated (or correlated) with Homebiogas. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Homebiogas has no effect on the direction of Israel China i.e., Israel China and Homebiogas go up and down completely randomly.

Pair Corralation between Israel China and Homebiogas

Assuming the 90 days trading horizon Israel China Biotechnology is expected to under-perform the Homebiogas. But the stock apears to be less risky and, when comparing its historical volatility, Israel China Biotechnology is 1.94 times less risky than Homebiogas. The stock trades about -0.05 of its potential returns per unit of risk. The Homebiogas is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  13,440  in Homebiogas on December 1, 2024 and sell it today you would lose (530.00) from holding Homebiogas or give up 3.94% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Israel China Biotechnology  vs.  Homebiogas

Israel China Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Israel China Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental drivers, Israel China is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Homebiogas

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Homebiogas are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Homebiogas sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Israel China and Homebiogas

The main advantage of trading using opposite Israel China and Homebiogas positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Israel China position performs unexpectedly, Homebiogas can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Homebiogas will offset losses from the drop in Homebiogas' long position.

The idea behind Israel China Biotechnology and Homebiogas pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.